https://www.mp-healthcare.com/news daily 0.75 2025-09-29 https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1566362360611-846NHLDK033Z1DGZOU06/image-asset.jpeg News https://www.mp-healthcare.com/news/trimtech-therapeutics-named-as-one-of-fierce-biotechs-fierce-15-for-2025 monthly 0.5 2025-09-29 https://www.mp-healthcare.com/news/blacksmith-medicines-granted-us-patent-covering-antibacterial-compounds-targeting-lpxc monthly 0.5 2025-07-03 https://www.mp-healthcare.com/news/draupnir-bio-completes-12-million-seed-round-to-progress-development-of-oral-small-molecule-degraders-of-extracellular-proteins-1 monthly 0.5 2024-07-17 https://www.mp-healthcare.com/news/pharmenable-therapeutics-and-sosei-heptares-expand-drug-discovery-collaboration monthly 0.5 2023-10-11 https://www.mp-healthcare.com/news/fund-raising-through-third-party-allotment-of-shares monthly 0.5 2023-03-22 https://www.mp-healthcare.com/news/editforce-and-mitsubishi-tanabe-pharma-enter-into-license-agreement monthly 0.5 2022-07-06 https://www.mp-healthcare.com/news/sonde-health-partners-with-gn-group-to-research-and-develop-new-vocal-biomarker-technology-to-detect-mild-cognitive-impairment monthly 0.5 2022-01-19 https://www.mp-healthcare.com/news/f-star-therapeutics-announces-merck-kgaa-darmstadt-germany-exercises-a-fourth-licensing-option-in-immuno-oncology-collaboration monthly 0.5 2022-01-05 https://www.mp-healthcare.com/news/korro-bio-completes-116m-series-b-financing-to-expand-the-frontier-of-genetic-medicine-through-its-pipeline-of-rna-editing-programs monthly 0.5 2022-01-05 https://www.mp-healthcare.com/news/liberothera-secures-300-million-jpy-financing-agreement-with-taiho-ventures monthly 0.5 2021-08-09 https://www.mp-healthcare.com/news/editforce-completed-fund-raising-by-third-party-allotment-and-amed-adopts-our-program monthly 0.5 2021-06-30 https://www.mp-healthcare.com/news/liberothera-closes-535-million-jpy-financing-to-develop-gpcr-targeting-therapeutics monthly 0.5 2021-05-14 https://www.mp-healthcare.com/news/biogen-and-capsigen-announce-collaboration-to-discover-and-develop-novel-aav-capsids-for-targeted-cns-and-neuromuscular-disorders monthly 0.5 2021-05-11 https://www.mp-healthcare.com/news/blacksmith-medicines-launches-with-seed-funding-and-a-research-collaboration-with-lilly monthly 0.5 2021-01-08 https://www.mp-healthcare.com/news/ribometrix-announces-collaboration-with-genentech-to-discover-and-develop-rna-targeted-small-molecule-therapeutics monthly 0.5 2021-01-08 https://www.mp-healthcare.com/news/f-star-therapeutics-completes-combination-with-spring-bank-pharmaceuticals-1 monthly 0.5 2020-11-20 https://www.mp-healthcare.com/news/korro-bio-closes-915-million-series-a-financing-to-advance-the-next-frontier-in-rna-therapeutics monthly 0.5 2020-09-10 https://www.mp-healthcare.com/news/spring-bank-pharmaceuticals-and-f-star-therapeutics-agree-to-combine-to-pursue-mission-of-creating-next-generation-immunotherapies-1 monthly 0.5 2020-07-30 https://www.mp-healthcare.com/news/merck-kgaa-darmstadt-germany-takes-an-early-option-in-immuno-oncology-collaboration monthly 0.5 2020-07-16 https://www.mp-healthcare.com/news/sonde-health-launches-new-voice-enabled-health-screening-tool-to-help-employers-return-to-work-during-the-global-pandemic monthly 0.5 2020-07-08 https://www.mp-healthcare.com/news/quralis-raises-42-million-series-a-financing-to-develop-new-therapies-for-amyotrophic-lateral-sclerosis-als monthly 0.5 2020-05-13 https://www.mp-healthcare.com/news/forge-enters-into-collaboration-with-roche-to-develop-novel-antibiotic-to-treat-lung-infections monthly 0.5 2020-05-13 https://www.mp-healthcare.com/news/sonde-health-appoints-david-liu-as-ceo-2 monthly 0.5 2019-10-28 https://www.mp-healthcare.com/news/vertex-and-ribometrix-establish-strategic-collaboration-to-discover-and-develop-rna-targeted-small-molecule-therapeutics monthly 0.5 2019-09-30 https://www.mp-healthcare.com/news/ribometrix-announces-78-million-in-new-funding-to-advance-rna-targeting-drug-discovery-platform monthly 0.5 2019-09-30 https://www.mp-healthcare.com/news/f-star-appoints-dr-louis-kayitalire-as-chief-medical-officer monthly 0.5 2019-10-02 https://www.mp-healthcare.com/news/sonde-completes-16-million-series-a-financing-round-to-advance-vocal-biomarker-technology-hz834-7dzfb-4rdg2 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/sonde-completes-16-million-series-a-financing-round-to-advance-vocal-biomarker-technology-hz834-7dzfb monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/sonde-completes-16-million-series-a-financing-round-to-advance-vocal-biomarker-technology-hz834 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/sonde-completes-16-million-series-a-financing-round-to-advance-vocal-biomarker-technology monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/quralis-raises-55-million-seed-round monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/quralis-has-won-the-amgen-golden-ticket-at-labcentral monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/quralis-has-won-the-amgen-golden-ticket-at-labcentral-fsr4s monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/merck-to-acquire-rigontec-rig-i-therapeutics-pioneer-advancing-leadership-in-immuno-oncology monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-expands-its-relationship-with-merck-through-a-new-strategic-collaboration-to-develop-bispecific-antibodies-in-immuno-oncology monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/rigontec-starts-first-in-human-phase-iii-trial-of-rig-i-agonist-rgt100-and-appoints-eugen-leo-as-chief-medical-officer monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/forge-therapeutics-raises-15m-series-a-financing-to-develop-first-novel-gram-negative-antibiotic-in-decades monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/forge-therapeutics-raises-15m-series-a-financing-to-develop-first-novel-gram-negative-antibiotic-in-decades-nrbf8 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/forge-therapeutics-raises-15m-series-a-financing-to-develop-first-novel-gram-negative-antibiotic-in-decades-nrbf8-pcjcl monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/forge-therapeutics-raises-15m-series-a-financing-to-develop-first-novel-gram-negative-antibiotic-in-decades-nrbf8-pcjcl-d5hap monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/forge-therapeutics-raises-15m-series-a-financing-to-develop-first-novel-gram-negative-antibiotic-in-decades-nrbf8-pcjcl-d5hap-f6dhd monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/fstar-announces-collaborative-agreement-with-denali-therapeutics-for-the-development-of-a-multispecific-antibody-platform-to-deliver-therapeutics-across-the-bloodbrain-barrier monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/miragen-therapeutics-initiates-first-clinical-trial-for-mrg-106-in-lymphoma-patients monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/thrasos-announces-promising-results-for-phase-2-thr-184-dose-ranging-clinical-study-for-the-prevention-of-acute-kidney-injury-aki monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-enters-into-collaborative-discovery-amp-development-agreement-with-abbvie-for-bispecific-antibodies-in-immuno-oncology monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/miragen-therapeutics-secures-41-million-series-c-financing-to-advance-two-microrna-programs-into-clinical-trials monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/thrasos-completes-enrollment-of-phase-2-thr-184-clinical-studay-for-acute-kidney-injury monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/thrasos-secures-21-million-to-complete-phase-2-study-of-thr-184-in-the-prevention-of-acute-kidney-injury-and-expand-the-companys-renal-portfolio monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-announces-the-formation-of-second-asset-centric-vehicle-f-star-beta-ltd monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/bristol-myers-squibb-enters-into-agreement-that-provides-an-exclusive-option-to-acquire-f-star-alpha-ltd-and-its-novel-her2-targeted-therapy monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/thrasos-announces-successful-formal-interim-analysis-and-clinical-update monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/janssen-affiliate-cilag-gmbh-international-acquires-covagen-ag monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-announces-positive-top-line-phase-1-results-for-novel-universal-pneumococcus-vaccine-candidate-gen-004 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-achieves-milestone-in-collaboration-with-boehringer-ingelheim monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-biosciences-inc-files-registration-statement-for-proposed-initial-public-offering monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/covagen-and-tanabe-research-laboratories-expand-strategic-research-collaboration-for-development-of-bispecific-fynomabs monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-biosciences-initiates-phase-1-study-of-vaccine-candidate-gen-004-to-prevent-infections-caused-by-pneumococcus monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-announces-formation-of-new-asset-centric-vehicle-f-star-alpha-ltd-with-94m-series-a-investment monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/pronota-is-to-receive-patent-on-biomarker-for-diagnosing-renal-failure-in-the-us-despite-prometheus monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/international-consortium-awarded-6-million-euro-to-validate-pre-eclampsia-early-detection-tests monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genkyotexs-nox-inhibitor-gkt137831-phase-i-data-presented-at-kidney-week-2012 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute-kidney-injury monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/covagen-enters-into-a-strategic-research-collaboration-and-license-agreement-with-mitsubishi-tanabe-for-the-development-of-bispecific-fynomabs monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-closes-30-million-in-series-c-financing-the-bill-amp-melinda-gates-foundation-and-cvf-join-as-new-investors monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-initiates-a-phase-12a-study-with-its-therapeutic-vaccine-candidate-for-herpes-simplex-virus-2-hsv-2 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genkyotex-raises-chf25-million-in-series-c-round-extension monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/pronotas-risk-stratification-test-breaks-new-ground-in-the-early-detection-of-pre-term-pre-eclampsia monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genkyotex-announces-successful-phase-ia-data-with-first-in-class-nox-inhibitor-gkt137831 monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/pronota-strengthens-management-team-former-vp-corporate-development-genzyme-joins-as-cbo monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/shire-to-acquire-ferrokin-biosciences-inc-and-its-phase-2-iron-chelator-treatment monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/pronota-announces-eur-37-million-series-c-financing-management-and-board-changes monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/syndexa-pharmaceuticals-expands-series-b1-financing-round-with-investment-by-mp-healthcare-venture-management-inc monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genkyotex-starts-phase-1-trial-with-first-in-class-nox-inhibitor-gkt137831-dual-nox14-inhibitor-targets-treatment-of-diabetic-nephropathy monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-and-merck-serono-to-collaborate-in-the-discovery-and-development-of-novel-targeted-biologics monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/fiercebiotech-names-f-star-a-2011-fierce-15-company monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genkyotex-raises-chf-18-million-in-a-series-c-venture-financing-to-develop-nox-enzyme-inhibitors monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/covagen-nominates-franz-hefti-as-new-member-of-the-board-of-directors monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/f-star-raises-15m-in-a-new-financing-led-by-sr-one monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/pronota-and-molecuence-announce-collaboration-in-protein-biomarker-discovery monthly 0.5 2019-08-27 https://www.mp-healthcare.com/news/genocea-biosciences-closes-35-million-series-b-financing monthly 0.5 2019-08-27 https://www.mp-healthcare.com/home daily 1.0 2019-10-11 https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1570831972398-WC9BSF6199C31TKVYFR2/Fcwithsurface.jpg Home https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1566360525620-1Q2OKSEG7U46AKV1K0XA/image-asset.jpeg Home https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1566445328675-83NM24F2HGOTBWC0T5V2/image-asset.jpeg Home https://www.mp-healthcare.com/about-us daily 0.75 2023-07-12 https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/2b742f91-7ebc-4da5-b4e4-4eda3825a0e2/ShotaOzawa29+%282%29.jpg About Us https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1569485122890-DAB4KF8QHSVEYPUG2DUO/JM_Headshot.jpg About Us https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1566361908537-GIX91FHTHXSXUZVQQ24M/image-asset.jpeg About Us https://www.mp-healthcare.com/contact daily 0.75 2024-04-26 https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1569872000729-8WZFMZUBHF7A3C8MREBL/shutterstock_133237775.jpg Contact https://www.mp-healthcare.com/portfolio daily 0.75 2019-08-21 https://images.squarespace-cdn.com/content/v1/5d447af6008631000189741b/1569872162574-Y4F40FZXJJF0BWY4ZKRW/shutterstock_1160144656.jpg Portfolio https://www.mp-healthcare.com/privacypolicy daily 0.75 2025-07-02 https://www.mp-healthcare.com/terms daily 0.75 2025-07-02